Safety, tolerability, pharmacokinetics, and pharmacodynamics of KN060, a humanized anti-FXI/FXIa dual-domain antibody, following single ascending doses in healthy Chinese subjects
在健康中国受试者中,单次递增剂量给药后,人源化抗FXI/FXIa双域抗体KN060的安全性、耐受性、药代动力学和药效学研究
期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2025.103322
Huang, Jie; Liu, Jinlong; Liu, Yaxin; Cao, Yichen; Sun, Wei; Dong, Yanrong; Li, Yuwei; Li, Jing; Wu, Qian; Yang, Xiaoyan; Yang, Shuang; Chen, Chuanpin; Yang, Guoping